Cargando…
Intraosseous administration into the skull: Potential blood–brain barrier bypassing route for brain drug delivery
Progress in treating central nervous system (CNS) disorders is retarded owing to a limited understanding of brain disease pathology. Additionally, the blood–brain barrier (BBB) limits molecular entry into the brain. Many approaches for brain drug delivery to overcome the BBB, such as BBB permeabilit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013776/ https://www.ncbi.nlm.nih.gov/pubmed/36925676 http://dx.doi.org/10.1002/btm2.10424 |